Xi'an Manareco(688550)
Search documents
瑞联新材发布2025年业绩快报
WitsView睿智显示· 2026-02-14 05:40
2月14号,瑞联新材发布2025年业绩快报。 报告期内,公司 实现营业收入 16.77亿元 元,同比增长14.95%;实现归属于母公司所有者的净 利润 3.11亿 元,同比增长23.48%;实现归属于母公司所有者的扣除非经常性损益的净利润 3.06亿 元,同比增长28.90%。 | 项目 | | 本报告期 | 上年同期 | 增减变动幅度(%) | | --- | --- | --- | --- | --- | | 营业总收入 | | 1,676,750,046.11 | 1,458,698,343.66 | 14.95 | | 营业利润 | | 357,669,740.56 | 292,543,730.24 | 22.26 | | 利润息额 | | 356,567,638.51 | 290,758,296.59 | 22.63 | | 归属于母公司所有者的净 | 利润 | 310,831,819.81 | 251,722,494.92 | 23.48 | | 归属于母公司所有者的扣 | 除非经常性损益的净利润 | 305,976,264.40 | 237.366.716.59 | 28.90 | | 基本每股 ...
西安瑞联新材料股份有限公司2025年度业绩快报公告
Xin Lang Cai Jing· 2026-02-13 18:33
Financial Performance - In 2025, the company achieved operating revenue of 1,676.75 million yuan, representing a year-on-year increase of 14.95% [3] - The net profit attributable to the parent company was 310.83 million yuan, up 23.48% year-on-year [3] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 305.98 million yuan, reflecting a year-on-year growth of 28.90% [3] Financial Position - As of the end of the reporting period, the company's total assets amounted to 3,646.89 million yuan, an increase of 7.33% from the beginning of the period [4] - The equity attributable to the parent company reached 3,285.55 million yuan, growing by 8.60% compared to the start of the period [4] - The net asset per share attributable to the parent company was 18.93 yuan, which is a 9.32% increase from the beginning of the period [4] Business Performance Factors - The growth in revenue for 2025 was primarily driven by the pharmaceutical and electronic materials sectors, with the pharmaceutical sector benefiting from inventory adjustments by key clients and increased sales of core products [5] - The electronic materials sector saw growth due to successful validation of semiconductor photoresist monomer materials and the introduction of certain packaging materials [5] - The company focused on enhancing operational efficiency and cost reduction, which contributed to improved profitability [5]
公告精选︱掌阅科技:2025年度AI短剧业务收入预计不超过2025年度主营业务收入的1%;嘉麟杰:实际控制人李兆廷被采取强制措施
Sou Hu Cai Jing· 2026-02-13 13:33
Group 1: Key Highlights - Zhangyue Technology (掌阅科技) expects AI short drama business revenue to not exceed 1% of its main business revenue in 2025 [1][2] - Actual controller of Jialinjie (嘉麟杰), Li Zhaoting, has been subjected to compulsory measures [1][2] - Jindan Technology (金丹科技) increases investment in a project for an annual production of 75,000 tons of polylactic acid biodegradable materials [1][2] Group 2: Contract Awards - Qinglong Pipe Industry (青龙管业) wins the bid for the first section of the heat supply pipeline project from Pengyang County Wangwa Power Plant to the county [1][2] - Gaode Infrared (高德红外) signs a contract for a complete equipment system [1][2] - ST Xintong (ST信通) signs a server procurement contract worth approximately 400 million yuan [1][2] Group 3: Financial Performance - Hanzhong Precision Machinery (汉钟精机) reports a net profit of 470 million yuan for 2025, a decrease of 45.54% year-on-year [1][2] - Fudan Microelectronics (复旦微电) anticipates a net profit of approximately 232 million yuan for 2025, down about 59.42% year-on-year [1][2] - Ruilian New Materials (瑞联新材) expects a net profit of 311 million yuan for 2025, an increase of 23.48% year-on-year [1][2] Group 4: Equity Transactions - Gongjin Co. (共进股份) plans to transfer 21.8340% equity of Chip Material Technology to Xinchang Technology [1][2] - Shengquan Group (圣泉集团) intends to acquire 13.50% equity of Shangbo Pharmaceutical for 4.29 million USD [1][2] - Changjiang Communication (长江通信) plans to exit 4.66% equity of Hangzhou Chenxiao through a targeted capital reduction [1][2] Group 5: Share Buybacks - Hualing Steel (华菱钢铁) has repurchased 0.8109% of its shares [1][2] - SanNuo Bio (三诺生物) has completed a share buyback plan, repurchasing 2.81% of its shares [1][2] Group 6: Shareholding Changes - Chunqiu Electronics (春秋电子) plans to reduce holdings by no more than 2% [1][2] - Guanghuan New Network (光环新网) intends to reduce holdings by no more than 3% [1][2] - ST Yigou (ST易购) plans to reduce holdings by no more than 2.5% [1][2] - Changjiang Communication (长江通信) plans to sell no more than 1 million shares of Changfei Optical Fiber [1][2] Group 7: Other News - Yingjixin (英集芯) is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [1][2] - Tianfeng Securities (天风证券) has received a notice of investigation from the China Securities Regulatory Commission [1][2] - Chuangshi Technology (创识科技) reports that its controlling shareholder has received a criminal judgment [1][2]
瑞联新材2025年度归母净利润3.11亿元,同比增长23.48%
Zhi Tong Cai Jing· 2026-02-13 10:36
报告期内,显示材料板块平稳发展,2025年度收入增长主要体现在医药及电子材料板块,其中医药板块 主力产品客户调整库存策略、核心产品进一步放量,推动销售收入增长;电子材料板块随着公司半导体 光刻胶单体材料验证工作的顺利推进,并成功导入部分封装材料产品,带动了相关业务的增长。本年度 公司持续着力提升经营管理效率,深化降本增效,通过节约挖潜、精益流程进一步完善管理体系,强化 研产供销协同,降低生产成本,推动盈利能力提升。 瑞联新材(688550.SH)披露2025年度业绩快报,2025年度实现营业收入16.77亿元,同比增长14.95%;归属 于母公司所有者的净利润3.11亿元,同比增长23.48%。 ...
瑞联新材(688550.SH)2025年度归母净利润3.11亿元,同比增长23.48%
智通财经网· 2026-02-13 10:34
智通财经APP讯,瑞联新材(688550.SH)披露2025年度业绩快报,2025年度实现营业收入16.77亿元,同 比增长14.95%;归属于母公司所有者的净利润3.11亿元,同比增长23.48%。 报告期内,显示材料板块平稳发展,2025年度收入增长主要体现在医药及电子材料板块,其中医药板块 主力产品客户调整库存策略、核心产品进一步放量,推动销售收入增长;电子材料板块随着公司半导体 光刻胶单体材料验证工作的顺利推进,并成功导入部分封装材料产品,带动了相关业务的增长。本年度 公司持续着力提升经营管理效率,深化降本增效,通过节约挖潜、精益流程进一步完善管理体系,强化 研产供销协同,降低生产成本,推动盈利能力提升。 ...
2月13日晚间重要公告一览
Xi Niu Cai Jing· 2026-02-13 10:24
Group 1 - RuiLian New Materials reported a total operating revenue of 1.677 billion yuan for 2025, an increase of 14.95% year-on-year, with a net profit of 311 million yuan, up 23.48% year-on-year [1] - China Shenhua's subsidiary, Guoneng Qingyuan Power, successfully put its fourth generator unit into commercial operation, expected to provide approximately 20 billion kWh of clean energy annually [2] - Qijiang Airlines announced a 6.04% year-on-year decline in passenger turnover for January 2026, with a passenger load factor of 84.03%, up 1.61% year-on-year [3] Group 2 - QiZheng Tibetan Medicine reported a total operating revenue of 2.416 billion yuan for 2025, a year-on-year increase of 3.34%, with a net profit of 646 million yuan, up 10.98% year-on-year [5] - QiaoYin Co. announced the termination of its artificial intelligence industry headquarters project due to changes in investment cooperation conditions [6] - New Point Software plans to use 90.81 million yuan of surplus raised funds for new projects, including AI-driven software development [7] Group 3 - High Measurement Co. announced plans for major shareholders and executives to reduce their holdings by up to 3.19% of the company's shares [8] - SAIC Group's subsidiary plans to establish a private equity fund with an initial scale of 2.5 billion yuan, focusing on solid-state batteries and chip localization [9] - Tianqi Lithium announced the resignation of its deputy general manager due to personal career planning [10] Group 4 - ZhongKong Technology reported a total operating revenue of 8.051 billion yuan for 2025, a decrease of 11.90%, with a net profit of 450 million yuan, down 59.70% year-on-year [11] - Spring Airlines reported a 6.28% year-on-year increase in total passenger volume for January 2026, with a total available ton-kilometers of 57,008.37 [12] - Qifan Cable's controlling shareholder reduced its stake by 3% through various trading methods [13] Group 5 - China Chemical signed contracts worth a total of 36.925 billion yuan in January 2026, with significant contracts exceeding 5 billion yuan totaling 11.371 billion yuan [19] - SaiTuo Bio received a CEP certificate for its raw material drug Betamethasone, which is used to treat allergies and autoimmune inflammation [20] - Giant Star Agriculture reported a sales revenue of 649 million yuan from commodity fat pigs in January 2026, with a sales volume of 404,400 pigs [23] Group 6 - Qinglong Pipe Industry's subsidiary won a 146 million yuan pipeline project [24] - Changshan Pharmaceutical announced that some of its products are expected to be selected for national centralized procurement [26] - Yangdian Technology completed the transfer of 12.96% of its shares through an agreement [27] Group 7 - Deepin Technology's investment fund introduced new limited partners and adjusted the capital contributions of some partners [28] - Qingyun Technology plans to pledge 25% of its shares for a loan application of up to 30 million yuan [29] - LaiMei Pharmaceutical reported a 57.20% year-on-year decline in net profit for 2025 [30] Group 8 - YouLiDe reported a 16.88% year-on-year decline in net profit for 2025, with total operating revenue of 1.221 billion yuan, up 7.99% [31] - Warner Pharmaceutical reported a net profit of 241 million yuan for 2025, an increase of 46.95% year-on-year [32] - LianRui New Materials reported a net profit of 293 million yuan for 2025, an increase of 16.42% year-on-year [33] Group 9 - HuaQin Technology expects a 24.28% year-on-year decrease in net profit for 2025, with projected revenue of 1.251 billion yuan, up 9.83% [34] - QiPai Technology's shareholder subscribed for 6.3 million shares, accounting for 5.49% of the total share capital [35] - Qilin Security's shareholders completed their planned share reductions without exceeding the original plan [36] Group 10 - Dameng Data announced the lifting of the detention of its senior vice president, allowing him to resume his duties [37] - Haiyou Engineering won a contract for the "NFPS COMP5" project worth approximately 4 billion USD, with the company's share exceeding 800 million USD [38] - Yatai Group plans to sell 20.81% of its shares in Northeast Securities, pending confirmation of financial statements [39]
瑞联新材(688550.SH):2025年度净利润3.11亿元,同比增长23.48%
Xin Lang Cai Jing· 2026-02-13 09:02
Core Viewpoint - 瑞联新材 (688550.SH) reported a strong performance for the fiscal year 2025, with significant growth in both revenue and net profit, driven by advancements in its pharmaceutical and electronic materials segments [1] Financial Performance - The company achieved an operating revenue of 1.677 billion yuan, representing a year-on-year increase of 14.95% [1] - The net profit attributable to shareholders reached 311 million yuan, marking a year-on-year growth of 23.48% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 306 million yuan, reflecting a year-on-year increase of 28.90% [1] Segment Performance - The revenue growth in 2025 was primarily driven by the pharmaceutical and electronic materials segments [1] - In the pharmaceutical segment, sales revenue increased due to clients adjusting inventory strategies and a further increase in core product sales [1] - The electronic materials segment saw growth as the company successfully advanced its semiconductor photoresist monomer material validation and introduced some packaging materials products [1] Operational Efficiency - The company focused on enhancing operational management efficiency and deepening cost reduction and efficiency improvement measures [1] - Efforts included cost savings, process optimization, and strengthening the coordination of research, production, supply, and sales to lower production costs and enhance profitability [1]
瑞联新材(688550) - 2025 Q4 - 年度业绩
2026-02-13 09:00
证券代码:688550 证券简称:瑞联新材 公告编号:2026-010 | 单位:元 | | --- | | 项目 | 本报告期 | 上年同期 | 增减变动幅度(%) | | --- | --- | --- | --- | | 营业总收入 | 1,676,750,046.11 | 1,458,698,343.66 | 14.95 | | 营业利润 | 357,669,740.56 | 292,543,730.24 | 22.26 | | 利润总额 | 356,567,638.51 | 290,758,296.59 | 22.63 | | 归属于母公司所有者的净 利润 | 310,831,819.81 | 251,722,494.92 | 23.48 | | 归属于母公司所有者的扣 除非经常性损益的净利润 | 305,976,264.40 | 237,366,716.59 | 28.90 | | 基本每股收益(元) | 1.80 | 1.45 | 24.14 | | 加权平均净资产收益率(%) | 9.88 | 8.52 | 增加 1.36 个百分点 | | | 本报告期末 | 本报告期初 | 增减变动幅度(% ...
瑞联新材:2025年净利润同比增长23.48%
2 1 Shi Ji Jing Ji Bao Dao· 2026-02-13 08:41
南财智讯2月13日电,瑞联新材发布2025年度业绩快报,报告期内公司实现营业收入16.77亿元,同比增 长14.95%;归属于上市公司股东的净利润3.11亿元,同比增长23.48%;基本每股收益1.80元,同比增长 24.14%。 ...
瑞联新材:上市以来累计现金分红占累计净利润比例近50%
Zheng Quan Ri Bao· 2026-02-12 12:36
(文章来源:证券日报) 证券日报网讯 2月12日,瑞联新材在互动平台回答投资者提问时表示,公司始终高度重视股东回报,上 市以来累计现金分红(不包含现金回购股份)占累计净利润比例近50%。对于您提出的相关建议,公司 将认真考虑,并结合经营业绩、现金流状况及未来发展规划综合拟定2025年度利润分配方案,并按规定 履行信息披露义务,敬请关注后续公告。 ...